Clearmind Medicine Inc
Company Profile
Business description
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company’s intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Contact
101-1220 West 6th Avenue
VancouverBCV6H 1A5
CANT: +1 604 260-1566
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 October 2025
Employees
1
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,579.50 | 49.70 | 0.58% |
CAC 40 | 7,853.47 | 16.68 | 0.21% |
DAX 40 | 23,695.59 | 168.58 | 0.72% |
Dow JONES (US) | 42,322.75 | 271.69 | 0.65% |
FTSE 100 | 8,633.75 | 48.74 | 0.57% |
HKSE | 23,278.09 | 175.07 | -0.75% |
NASDAQ | 19,112.32 | 34.49 | -0.18% |
Nikkei 225 | 37,659.39 | 96.12 | -0.25% |
NZX 50 Index | 12,813.83 | 66.99 | -0.52% |
S&P 500 | 5,916.93 | 24.35 | 0.41% |
S&P/ASX 200 | 8,345.30 | 47.80 | 0.58% |
SSE Composite Index | 3,361.22 | 19.60 | -0.58% |